Pfizer Inc (NYS: PFE) Report Date 2020 2019 Cash & cash equivalents Short-term investments Trade accounts receivable Inventories Current tax assets Other current assets Assets held for sale Total current assets Equity-method investments Long-term investments Property, plant & equipment 1,784,000 1,305,000 10,437,000 8,525,000 2018 1,139,000 17,694,000 2017 1,342,000 18,650,000 7,930,000 8,724,000 8,025,000 8,221,000 8,047,000 8,284,000 7,508,000 7,577,000 3,264,000 3,344,000 3,374,000 3,050,000 3,438,000 2,600,000 2,461,000 2,289,000 167,000 21,000 9,725,000 12,000 35,067,000 32,803,000 49,926,000 41,141,000 16,856,000 17,133,000 3,406,000 3,014,000 2,767,000 7,015,000 13,900,000 13,967,000 13,385,000 13,865,000 Identifiable intangible assets 28,471,000 35,370,000 35,210,000 48,742,000 Goodwill 49,577,000 58,653,000 53,411,000 55,952,000 Noncurrent deferred tax assets & other noncurrent tax assets 2,383,000 2,099,000 1,924,000 1,855,000 Other noncurrent assets 4,569,000 4,450,000 2,799,000 3,227,000 Total assets 154,229,000 167,489,000 159,422,000 171,797,000 Liabilities Short-term borrowings, including current portion of long-term debt 2,703,000 16,195,000 8,831,000 9,953,000 Trade accounts payable 4,309,000 4,220,000 4,674,000 4,656,000 Dividends payable 2,162,000 2,104,000 2,047,000 2,029,000 Income taxes payable 1,049,000 980,000 1,265,000 477,000 Accrued compensation & related items 3,057,000 2,722,000 2,398,000 2,197,000 Other current liabilities 12,640,000 11,083,000 12,643,000 11,115,000 Total current liabilities 25,920,000 37,304,000 31,858,000 30,427,000 Long-term debt Pension benefit obligations Postretirement benefit obligations Noncurrent deferred tax liabilities Other taxes payable Other noncurrent liabilities Total liabilities 37,133,000 35,955,000 32,909,000 33,538,000 4,766,000 5,638,000 5,272,000 5,926,000 645,000 1,124,000 1,338,000 1,504,000 4,063,000 5,578,000 3,700,000 3,900,000 11,560,000 12,126,000 14,737,000 18,697,000 6,669,000 6,317,000 90,756,000 104,042,000 5,850,000 95,664,000 6,149,000 100,141,000 Stockholders' Equity Preferred stock 17,000 Common stock 470,000 Additional paid-in capital 88,674,000 468,000 87,428,000 19,000 467,000 86,253,000 21,000 464,000 84,278,000 Treasury stock 110,988,000 110,801,000 101,610,000 89,425,000 Retained earnings (accumulated deficit) 96,770,000 Accumulated other comprehensive income (loss) (11,688,000) Equity attributable to noncontrolling interests Total equity (deficit) 235,000 63,473,000 97,670,000 (11,640,000) 305,000 63,447,000 (11,275,000) 63,758,000 89,554,000 85,291,000 350,000 (9,321,000) 348,000 71,656,000